This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Educating, Informing, And Successfully Preparing The Marketplace For New Bio-Pharma Products

CHAPEL HILL, N.C., March 17, 2013 /PRNewswire/ -- Given the rapid rate that the pharmaceutical marketplace is evolving at, it has become more critical than ever for companies with new product launches to effectively educate the marketplace upon market entry. While educating and shaping the market for new bio-pharma products has been critical to the development process for years, how companies are choosing to complete these tasks is quickly changing – resulting in new, strategic marketplace practices.

To analyze and understand these practices, research and consulting firm Best Practices, LLC developed a study that helps to pinpoint effective practices that will benefit thought leaders when preparing for a new product launch. The report, Educating KOLs, Physicians, Patients and Payers to Support Successful Product Launches, identifies and captures scores of market-education benchmarks, key practices, lessons learned, and operational pitfalls to avoid when informing and preparing the marketplace for new products.

The 139-page report contains almost 500 metrics to help inform launch leaders on the most effective type and timing of market education practices during the full development cycle. Executives and managers involved in market education efforts for new products can use this research to compare their market education tactics and strategies with those of leading organizations. Key study objectives included:

  • Identification of Key Education Tactics for Thought Leaders, Physicians, Patients, and Payers
  • Identification of Key Timing for Educational Activities for KOLs, Physicians, Patients and Payers
  • Assessment of Key Market Education Practices, including Thought Leader Activities, CME, Scientific Publication Strategy and Tactics, Patients and Patient Advocacy Education, Clinical Trials & Payer Education
  • Description of Critical Market Education Pitfalls and Future Trends

The research project attracted 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies including 12 of the Top 20 pharma companies. Additionally, the research reflects on nine deep-dive interviews with selected participants.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,444.11 +56.90 0.33%
S&P 500 2,031.10 +1.55 0.08%
NASDAQ 4,705.1710 +23.6740 0.51%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs